Blocking IL-6 could not only slow tumor progression but also reactivate NK cells suppressed by peri-pancreatic adipose tissue or tumor-infiltrating cells, offering a promising therapeutic approach for the treatment of pancreatic tumors. Here, IL6 is linked to neoplasm.